Creating a database for melanoma in children and young adults
Precision Medicine for L/GCMN and Melanoma 1 (Precis-mel 1)
This study is trying to create a detailed database for melanoma in kids and young adults to see how well they do and improve treatment options for them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Sex | All |
| Sponsor | Fundacion Clinic per a la Recerca Biomédica Academic / other |
| Locations | 1 site (Barcelona, Catalonia) |
| Trial ID | NCT06608420 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop a comprehensive database for melanoma that includes cohorts of children, adolescents, and young adults. It will utilize retrospective data collection to analyze survival rates and sentinel lymph node positivity in these populations. The study will also adapt existing precision medicine algorithms for pediatric use and implement transfer learning techniques to enhance model accuracy with limited data. By integrating expert medical opinions, the study seeks to refine treatment approaches for melanoma in younger patients.
Who should consider this trial
Good fit: Ideal candidates for this study are melanoma patients of any age with a histopathological confirmation of their diagnosis.
Not a fit: Patients without a melanoma diagnosis or those who do not consent to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved survival outcomes and personalized treatment strategies for young melanoma patients.
How similar studies have performed: Other studies have shown success in using machine learning and precision medicine approaches for adult melanoma, but this specific focus on pediatric populations is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Melanoma patients of any age with histopathological confirmed melanoma Exclusion Criteria: * Not having a melanoma diagnosis * Not having signed the informed consent * Records prior to the year 2012 (as data might not accurately reflect current practices and treatment outcomes)
Where this trial is running
Barcelona, Catalonia
- Hospital Clínic de Barcelona (Dermatology service) — Barcelona, Catalonia, Spain (Recruiting)
Study contacts
- Study coordinator: Susana Puig Sardà, MD, PhD
- Email: spuig@clinic.cat
- Phone: +34932275400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.